Navigation Links
Halozyme Reports Fourth Quarter and Year End 2012 Financial Results
Date:2/25/2013

SAN DIEGO, Feb. 25, 2013 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) today reported financial results for the fourth quarter and year ended December 31, 2012.

(Logo: http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

"2012 was another productive year marked by key partner regulatory filings in Europe, as well as our establishment of a new collaboration with Pfizer," said Gregory I. Frost, Ph.D., President and Chief Executive Officer, Halozyme. "These advancements, coupled with the continued progress of our own pipeline products, leave Halozyme well-positioned for continued growth in 2013."

Fourth Quarter Highlights Highlights of Halozyme's fourth quarter and recent activities include:

  • Pfizer Collaboration: Entry into a worldwide Collaboration and License Agreement with Pfizer Inc. for the purpose of developing and commercializing products combining proprietary Pfizer biologics with Halozyme's Enhanze™ Technology.  Pfizer has elected three exclusive licenses to therapeutic targets in primary care and specialty care indications, and has the right to elect up to three additional targets upon payment of additional fees.
  • Cinryze® Phase 2 Trial: ViroPharma initiated a Phase 2b study to evaluate the safety and efficacy of subcutaneous (SC) administration of Cinryze (C1 esterase inhibitor [human]) in adolescents and adults with hereditary angioedema (HAE) for prevention of HAE attacks.
  • MabThera® EMA Filing: Roche submitted a line extension application to the European Medicines Agency (EMA) for a subcutaneous (SC) formulation of MabThera (rituxumab). MabThera SC uses Halozyme's Enhanze Technology, which enables the injection of large v
    '/>"/>

  • SOURCE Halozyme Therapeutics, Inc.
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Halozyme Announced Roche Filed A Marketing Authorization Application For Subcutaneous MabThera
    2. Halozyme Therapeutics To Present At The Lazard Capital Markets 9th Annual Healthcare Conference
    3. Halozyme to Host Third Quarter Financial Results Conference Call
    4. Halozyme Reports Second Quarter 2012 Financial Results
    5. Halozyme Confirms Baxter Has Received A Complete Response Letter For HyQ BLA
    6. Halozymes Ultrafast Insulin Formulations Improved Postprandial Glycemic Control in Patients Living with Type 1 Diabetes: Phase 2 Study Results Presented at ADA 2012
    7. Halozyme Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
    8. Halozyme Reports First Quarter 2012 Financial Results
    9. Halozyme to Host First Quarter 2012 Financial Results Conference Call
    10. Novartis Reports Omalizumab Significantly Improved Chronic Idiopathic Urticaria Symptoms in Patients Who Failed Standard Therapy
    11. Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/19/2014)... , Sept. 19, 2014 UBM Medica ... a leading online community to help oncologists and other ... available regarding the use of targeted therapies and immunotherapies, ... research and treatment.  Every September, ... way to raise awareness about blood cancers—helping to increase ...
    (Date:9/19/2014)... SOUTH EASTON, Mass. , Sept. 19, 2014 ... the "Company") today announced it has received and ... throughput Barozyme HT48 instruments and has begun to ... believes the first instrument will be ready for ... will be built and released at a rate ...
    (Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners ... Future to Benefit the Radiation Oncology Institute (ROI), hosted ... at Golden Gate Park in San Francisco.  ... Moore , CEO of Radiation Business Solutions, "but ... have raised over $70,000 for the ROI this year. ...
    Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
    (Date:9/20/2014)... New PharmaPoint Drug Evaluation report, ... 2023?. The asthma market saw very slow growth ... saturated with relatively efficacious standard therapies, such as ... and long-acting beta-agonists (ICS/LABAs), and leukotriene modifiers, and ... the launch of seven novel targeted biologic agents ...
    (Date:9/20/2014)... 2014 Traditionally dentists have advised their patients ... Charlotte Dentistry is re-visiting that advice and changing his ... coffee and wine have on oral health. “There’s good news ... coffee may be beneficial in protecting against gum disease, and ... study on coffee was from the September 2014 issue ...
    (Date:9/20/2014)... September 20, 2014 QueenBeeTickets.com is ready ... star’s tour performances. She will visit many cities in ... until the 16th of April. , Click Here ... Tour tickets at QueenBeeTickets.com. , The star’s fans are ... see their favorite young singer in a live performance. ...
    (Date:9/20/2014)... Everett, WA (PRWEB) September 20, 2014 “Motherhood ... Health Center of Snohomish in their latest article , ... the best that you can—and that’s what we want to ... what services they need and should expect from their Family ... the following days of new motherhood. , To learn ...
    (Date:9/19/2014)... “Copay coupons,” a drug manufacturer marketing tactic ... patients with prescription drug coverage, may now be infiltrating ... from the Department of Health and Human Services ... prohibit suppliers from offering side-payments to increase sales of ... The report highlights that two recent surveys, including one ...
    Breaking Medicine News(10 mins):Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 2Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 3Health News:Symbicort Asthma Market Forecasts to 2023 - Overview, Efficacy, Safety & SWOT Analysis in New Report Available at LifeScienceIndustryResearch.com 4Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Discount Ariana Grande Tickets: QueenBeeTickets.com Delights Fans with Discount Concert Tickets for Ariana Grande’s 2015 Honeymoon Tour 2Health News:Newest Article from Community Health Center of Snohomish County Highlights The Importance of Proper Health Care for Expectant Mothers 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2
    ... Rental Suites ... On Track to Open in Late 2008, BETHESDA, Md., Feb. ... managed by Sunrise,Senior Living, Inc. (NYSE: SRZ ), continues to ... 140 condominiums have already,been reserved to date and construction on the ...
    ... revolution taking place,and it,s changing the face of cold-beverage ... that,s more sophisticated than traditional,sodas. Many are looking for ... past, finding a healthy and delicious bottled,drink was no ... are,definitely something to get excited about., "The beverage ...
    ... MedCath Corporation,(Nasdaq: MDTH ) announced today that ... relationship with Solaris Health System of Edison, N.J., ... new venture to manage the,catheterization laboratories of Solaris,s ... Regional Medical Center. Solaris, local,cardiologists, and MedCath will ...
    ... LOS ANGELES, Feb. 19 With Presidential,candidates campaigning ... basis,California cosmetic dentist Michael Kosdon has had ample ... observations, Dr. Kosdon has,picked a winner., "I ... brighter, more,crowd-pleasing smile than Hillary Clinton," says Kosdon, ...
    ... OREM, Utah, Feb. 19 Aribex, Inc., the ... NOMAD Pro, the,most-advanced intraoral X-ray system available. The ... NOMAD X-ray system., (Photo: http://www.newscom.com/cgi-bin/prnh/20080219/LATU057 ), ... that dental radiography is,performed by allowing an operator ...
    ... Company will donate money to non-profit organizations supporting medication, error prevention ... ... wristband, SAN BRUNO, Calif., Feb. ... announced the launch of a new,brand awareness campaign to focus public ...
    Cached Medicine News:Health News:Fox Hill Senior Condominium Development Thrives During National Housing Slump 2Health News:Fox Hill Senior Condominium Development Thrives During National Housing Slump 3Health News:Fox Hill Senior Condominium Development Thrives During National Housing Slump 4Health News:The Search for Healthier Drinks Turns Up Yerba Mate 2Health News:MedCath Announces Venture With Two New Jersey Hospitals 2Health News:MedCath Announces Venture With Two New Jersey Hospitals 3Health News:Smiling on the Campaign Trail - Cosmetic Dentist Michael Kosdon Rates the Candidates 2Health News:Aribex Unveils New Handheld Intraoral X-ray System - NOMAD Pro 2Health News:First DataBank Launches Campaign to Focus Public and Industry Attention on Medication Error Prevention 2Health News:First DataBank Launches Campaign to Focus Public and Industry Attention on Medication Error Prevention 3
    ... Until now, laborious custom fabrication was required ... was limited and modifications in response to ... cumbersome.,The GunSlinger evolved from two years of ... teaching hospital. This orthosis can be quickly ...
    ... abduction of shoulder, elbow, wrist, and hand. ... is supported by the opposite shoulder. Abduction ... Foam arm support attaches to pillow wedge ... be attached anywhere along length of arm. ...
    ... is designed for the management of ... fractures. The lightweight anatomical design achieves ... for optimal control of humeral segments ... the shoulder and elbow joints. It ...
    Provides secure fracture immobilization while allowing for full range of motion at shoulder and elbow...
    Medicine Products: